Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Smoldering Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07684274
What this trial is testing

Early Screening for Multiple Myeloma Based on Liquid Biopsy cfDNA Fragmentomics

Who this might be right for
Multiple Myeloma (MM)Smoldering Multiple Myeloma (SMM)MGUS
The First Affiliated Hospital with Nanjing Medical University 290
Early research (Phase 1)Study completedNCT01718899
What this trial is testing

Phase 1/2a Study of Cancer Vaccine to Treat Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
OncoPep, Inc. 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT03673826
What this trial is testing

Carfilzomib, Lenalidomide and Dexamethasone Versus Lenalidomide and Dexamethasone in High- Risk SMM

Who this might be right for
Smouldering Myeloma
Stichting Hemato-Oncologie voor Volwassenen Nederland 58
Large-scale testing (Phase 3)Looking for participantsNCT07393282
What this trial is testing

Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

Who this might be right for
High Risk Smoldering Multiple Myeloma (HR-SMM)
Regeneron Pharmaceuticals 270
Testing effectiveness (Phase 2)Ended earlyNCT03850522
What this trial is testing

PD-L1 Peptide Vaccination in High Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
Lene Meldgaard Knudsen 6
Testing effectiveness (Phase 2)Looking for participantsNCT06140524
What this trial is testing

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Smoldering Multiple Myeloma (SMM)
Regeneron Pharmaceuticals 116
Not applicableLooking for participantsNCT06212323
What this trial is testing

Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial

Who this might be right for
Smoldering Multiple Myeloma
University of Utah 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05767359
What this trial is testing

CAR- PRISM (PRecision Intervention Smoldering Myeloma)

Who this might be right for
Multiple MyelomaSmoldering Multiple Myeloma
Dana-Farber Cancer Institute 20
Not applicableLooking for participantsNCT06365060
What this trial is testing

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
Tufts Medical Center 400
Testing effectiveness (Phase 2)Study completedNCT00083382
What this trial is testing

Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide

Who this might be right for
Multiple Myeloma
University of Arkansas 83
Testing effectiveness (Phase 2)WithdrawnNCT03952832
What this trial is testing

Leflunomide in Treating Patients With High-Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Plasma Cell Myeloma
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT02916771
What this trial is testing

Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
Dana-Farber Cancer Institute 61
Testing effectiveness (Phase 2)Study completedNCT01884688
What this trial is testing

UARK 2013-05 A Study of Autologous Expanded Natural Killer Cell Therapy for Asymptomatic Multiple Myeloma

Who this might be right for
Asymptomatic Multiple Myeloma
University of Arkansas 3
Not applicableLooking for participantsNCT05640843
What this trial is testing

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
Memorial Sloan Kettering Cancer Center 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT03236428
What this trial is testing

Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma

Who this might be right for
Monoclonal GammopathySmoldering Multiple Myeloma
Dana-Farber Cancer Institute 42
Not applicableLooking for participantsNCT03717844
What this trial is testing

Registry for Adults With Plasma Cell Disorders (PCD's)

Who this might be right for
Multiple MyelomaAmyloidosisCryoglobulinemia+6 more
UNC Lineberger Comprehensive Cancer Center 2,000
Not applicableStudy completedNCT04615572
What this trial is testing

Screening to Improve Survival in AL Amyloidosis

Who this might be right for
Smoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
Tufts Medical Center 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT02415413
What this trial is testing

Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
PETHEMA Foundation 90
Not applicableLooking for participantsNCT06895291
What this trial is testing

Whole Body MRI in Oncology

Who this might be right for
LymphomaAdvanced Prostate CancerAdvanced Breast Cancer+3 more
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 1,000
Testing effectiveness (Phase 2)Study completedNCT04731844
What this trial is testing

Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer

Who this might be right for
Prostate CancerMultiple MyelomaSmoldering Multiple Myeloma (SMM)+1 more
University of Rochester 30
Next Page